Combo of diabetes, depression increases post-MI mortality

February 27, 2012
Combo of diabetes, depression increases post-MI mortality

(HealthDay) -- Having both diabetes and depression significantly increases the risk of dying in the years following a heart attack, beyond the increased risk from either condition alone, according to a study published in the March issue of Diabetes Care.

Mariska Bot, from Tilburg University in the Netherlands, and colleagues analyzed data from two multicenter cohort studies, including 2,704 patients who were hospitalized for . Diabetes and depression (defined as a score ≥10) were evaluated during hospitalization. Mortality data were available for 2,525 patients, who were followed for an average of 6.2 years.

The researchers found that, during follow-up, 439 patients died. The mortality rate was 14 percent for patients without diabetes and depression, and was 23, 22, and 47 percent for those with diabetes only, depression only, and both diabetes and depression, respectively. After adjusting for other variables, the hazard ratios for all-cause mortality were 1.38 for patients with diabetes only, 1.39 for those with depression only, and 2.90 for patients with both diabetes and depression.

"We observed an increased mortality risk in post-myocardial infarction patients with both diabetes and depression, beyond the association with mortality of diabetes and depression alone," the authors write.

One of the multicenter cohort studies was funded by the pharmaceutical industry.

Explore further: With diabetes, untreated depression can lead to serious eye disease

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Recommended for you

Gut bacteria imbalance increases diabetes risk

July 13, 2016

Currently, scientists think the major contributors to insulin resistance are excess weight and physical inactivity, yet ground-breaking new research by an EU funded European-Chinese team of investigators called MetaHit have ...

Which diabetes drug is best?

July 19, 2016

(HealthDay)—No single drug to treat type 2 diabetes stands out from the pack when it comes to reducing the risks of heart disease, stroke or premature death, a new research review finds.

Team explores genetic architecture of type 2 diabetes

July 11, 2016

New research from a large international team of scientists offers a more complete picture of the genes responsible for type 2 diabetes, demonstrating that previously identified common alleles shared by many in the world are ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.